LivaNova PLC(LIVN)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #687 of 2,961 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
LIVN Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for LivaNova PLC (LIVN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores LIVN at 62.7/100 on a 32-signal composite quality model, placing it at rank #687 of 2,961 stocks — the top 25% of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), LivaNova PLC reports quarterly revenue of $390.6M, net income of $108.6M, an operating margin of 12.7%. Top institutional holders of LIVN by reported 13-F value include BlackRock, PRIMECAP MANAGEMENT, FMR, based on the most recent SEC filings. LIVN trades on the Nasdaq exchange and files with the SEC under CIK 1639691. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LIVN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for LivaNova PLC directly from SEC EDGAR. LivaNova PLC's 13F Pro composite quality score has ranged between 46 and 63 since 2026, currently 62.7 — an improving long-term trajectory across 48 quarterly and live scoring snapshots.
Revenue
Q2 2026
$390.6M
Net Income
Q2 2026
$108.6M
Free Cash Flow
Q2 2026
$35.0M
Operating Margin
Q2 2026
12.7%
ROIC
Q2 2026
12.2%
D/E Ratio
Q2 2026
0.22
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+10.7% YoYNet Income
-483.5% YoYOperating Income
+54.5% YoYEPS (Diluted)
-483.6% YoYTotal Assets
+4.0% YoYTotal Debt
-44.0% YoYOp. Cash Flow
+39.0% YoYFree Cash Flow
+27.5% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.39B +10.7% | $1.25B +8.7% | $1.15B +12.9% | $1.02B -1.3% | $1.04B +10.8% | $934.2M |
| Net Income | $-242.5M -483.5% | $63.2M +260.4% | $17.5M +120.3% | $-86.2M +36.5% | $-135.8M +61.1% | $-348.8M |
| Operating Income | $199.4M +54.5% | $129.1M +288.4% | $-68.5M +10.8% | $-76.8M -9689.8% | $-784.0K +99.7% | $-273.9M |
| EPS (Diluted) | $-4.45 -483.6% | $1.16 +262.5% | $0.32 +119.9% | $-1.61 +39.9% | $-2.68 +62.7% | $-7.18 |
| Total Assets | $2.61B +4.0% | $2.51B +3.2% | $2.43B +5.9% | $2.29B +4.3% | $2.20B -8.7% | $2.41B |
| Total Debt | $438.4M -44.0% | $782.3M +25.8% | $621.6M +6.6% | $583.3M -15.9% | $693.4M +3.1% | $672.4M |
| Operating Cash Flow | $254.3M +39.0% | $183.0M +144.3% | $74.9M +7.1% | $69.9M -31.8% | $102.5M +229.1% | $-79.4M |
| Free Cash Flow | $173.3M +27.5% | $135.9M +240.4% | $39.9M -8.0% | $43.4M -43.7% | $77.1M +167.3% | $-114.4M |
Get alerted when LIVN's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for LivaNova PLC including:
Top Institutional Holders of LIVN
BlackRock, Inc.
$622.1M7,565,342 shPRIMECAP MANAGEMENT CO/CA/
$342.8M4,168,377 shFMR LLC
$258.8M3,147,068 shHood River Capital Management LLC
$211.0M2,565,477 shAQR CAPITAL MANAGEMENT LLC
$191.0M2,356,191 shInvesco Ltd.
$184.0M2,237,319 shArtisan Partners Limited Partnership
$182.9M2,224,763 shSTATE STREET CORP
$178.1M2,165,863 shAMERICAN CENTURY COMPANIES INC
$165.6M2,013,774 shDIMENSIONAL FUND ADVISORS LP
$151.7M1,845,285 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $622.1M | 7,565,342 |
| PRIMECAP MANAGEMENT CO/CA/ | $342.8M | 4,168,377 |
| FMR LLC | $258.8M | 3,147,068 |
| Hood River Capital Management LLC | $211.0M | 2,565,477 |
| AQR CAPITAL MANAGEMENT LLC | $191.0M | 2,356,191 |
| Invesco Ltd. | $184.0M | 2,237,319 |
| Artisan Partners Limited Partnership | $182.9M | 2,224,763 |
| STATE STREET CORP | $178.1M | 2,165,863 |
| AMERICAN CENTURY COMPANIES INC | $165.6M | 2,013,774 |
| DIMENSIONAL FUND ADVISORS LP | $151.7M | 1,845,285 |
Companies Similar to LIVN
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Inspire Medical Systems, Inc.
VERACYTE, INC.
TransMedics Group, Inc.
Vericel Corp
ANI PHARMACEUTICALS INC
LEMAITRE VASCULAR INC
Innoviva, Inc.
Envista Holdings Corp
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put LIVN on your watchlist
Track score changes the day LivaNova PLC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is LIVN a good stock to buy?
13F Pro's AI-powered analysis of LivaNova PLC (LIVN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for LIVN are available on the LIVN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. LIVN is classified as a mid company.
Which hedge funds own LIVN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling LIVN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of LivaNova PLC's investment landscape.